tradingkey.logo
tradingkey.logo
Search

EyePoint Pharmaceuticals Inc

EYPT
Add to Watchlist
4.250USD
+0.020+0.47%
Close 09-11 16:00ET
361.17MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.47%

5 Days

-7.21%

1 Month

-68.47%

6 Months

-67.80%

Year to Date

-76.74%

1 Year

-68.16%

Key Figures

4.300Open
4.340High
258.50KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.30%Turnover Ratio
4.230Prev. Close
4.165Low
1.10MTurnover
LossP/E Static
2.17P/B
0.00%Div Yield TTM
-83.47%ROA
19.11052wk High
35.49Volume Ratio
-130.87MNet Profit
84.98MShares
-3.5053EPS TTM
1.74Beta
-102.71%ROE
3.95052wk Low
4.14%Amplitude
100.00%Gross Margin
361.17MMarket Cap
3.89Reward/Risk
6.11%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

EyePoint Pharmaceuticals Inc's Score

-0.50vs previous score
Forecast7.69
Financial Health5.81
Technical6.90
Valuation Dimensions6.57
Institutional Confidence10.00
Risk Assessment2.23

Media Coverage

Coverage Level

Very Low
Very High
Negative-

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
28.600Target Price
+576.12%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy44444444
Buy34888888
Hold65000000
Sell00000000
Strong Sell00000000

EyePoint Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.09/-0.95
Revenue / Forecast
507.00K/406.86K

EyePoint Pharmaceuticals Inc Profile

SectorPharmaceuticals
Ticker SymbolEYPT
Number of employees165
CountryUnited States of America

Ownership

ShareholdersProportion
Cormorant Asset Management, LP9.86%
Suvretta Capital Management, LLC9.34%
BlackRock Institutional Trust Company, N.A.6.48%
Franklin Advisers, Inc.5.89%
Shareholder TypesProportion
Hedge Fund37.20%
Investment Advisor29.27%
Investment Advisor/Hedge Fund29.25%
Private Equity3.87%

FAQs

What is the current price of EyePoint Pharmaceuticals Inc (EYPT)?

The current price of EyePoint Pharmaceuticals Inc (EYPT) is 4.23.

What is the symbol of EyePoint Pharmaceuticals Inc?

The ticker symbol of EyePoint Pharmaceuticals Inc is EYPT.

What is the 52-week high of EyePoint Pharmaceuticals Inc?

The 52-week high of EyePoint Pharmaceuticals Inc is 19.11.

What is the 52-week low of EyePoint Pharmaceuticals Inc?

The 52-week low of EyePoint Pharmaceuticals Inc is 3.95.

What is the market capitalization of EyePoint Pharmaceuticals Inc?

The market capitalization of EyePoint Pharmaceuticals Inc is 359.05M.

Is EyePoint Pharmaceuticals Inc (EYPT) currently rated as Buy, Hold, or Sell?

According to analysts, EyePoint Pharmaceuticals Inc (EYPT) has an overall rating of Buy, with a price target of 28.60.

What is the Earnings Per Share (EPS TTM) of EyePoint Pharmaceuticals Inc (EYPT)?

The Earnings Per Share (EPS TTM) of EyePoint Pharmaceuticals Inc (EYPT) is -3.51.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.